These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8872819)

  • 1. Hypertension control in multi-ethnic primary care clinics.
    Pavlik VN; Hyman DJ; Vallbona C
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S19-23. PubMed ID: 8872819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of blood pressure control among hypertensives in community health centers.
    Shelley D; Tseng TY; Andrews H; Ravenell J; Wu D; Ferrari P; Cohen A; Millery M; Kopal H
    Am J Hypertens; 2011 Dec; 24(12):1318-23. PubMed ID: 21866185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects.
    Liu X; Zhu T; Manojlovich M; Cohen HW; Tsilimingras D
    PLoS One; 2017; 12(8):e0182807. PubMed ID: 28793323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
    Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
    Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA).
    Kramer H; Han C; Post W; Goff D; Diez-Roux A; Cooper R; Jinagouda S; Shea S
    Am J Hypertens; 2004 Oct; 17(10):963-70. PubMed ID: 15485761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
    Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ
    JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectory of systolic blood pressure in a low-income, racial-ethnic minority cohort with diabetes and baseline uncontrolled hypertension.
    Zullig LL; Liang Y; Vale Arismendez S; Trevino A; Bosworth HB; Turner BJ
    J Clin Hypertens (Greenwich); 2017 Jul; 19(7):722-730. PubMed ID: 28371157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic differences in nocturnal blood pressure decline in treated hypertensives.
    Hyman DJ; Ogbonnaya K; Taylor AA; Ho K; Pavlik VN
    Am J Hypertens; 2000 Aug; 13(8):884-91. PubMed ID: 10950396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity.
    Hicks LS; Fairchild DG; Horng MS; Orav EJ; Bates DW; Ayanian JZ
    Hypertension; 2004 Oct; 44(4):429-34. PubMed ID: 15326088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC 7 guidelines.
    Krousel-Wood M; Muntner P; Carson A; Anderson AH; Delaune E; Cushman WC; Cutler JA; Piller LB; Goforth GA; Whelton PK
    J Clin Hypertens (Greenwich); 2012 May; 14(5):277-83. PubMed ID: 22533653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A; Punzi H; Luo X; Stapff M
    Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension awareness and control in an inner-city African-American sample.
    Pavlik VN; Hyman DJ; Vallbona C; Toronjo C; Louis K
    J Hum Hypertens; 1997 May; 11(5):277-83. PubMed ID: 9205933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the accuracy of clinic blood pressure measurement?
    Sala C; Santin E; Rescaldani M; Cuspidi C; Magrini F
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):244-8. PubMed ID: 15752953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.